Insensitivity of visual assessment of hippocampal atrophy in familial Alzheimer’s disease
暂无分享,去创建一个
[1] Kiralee M. Hayashi,et al. The topography of grey matter involvement in early and late onset Alzheimer's disease. , 2007, Brain : a journal of neurology.
[2] M. Tusié-Luna,et al. Founder effect for the Ala431Glu mutation of the presenilin 1 gene causing early-onset Alzheimer’s disease in Mexican families , 2006, Neurogenetics.
[3] Nick C Fox,et al. Amyloid, hypometabolism, and cognition in Alzheimer disease , 2007, Neurology.
[4] J. Cummings,et al. Current concepts of mild cognitive impairment and their applicability to persons at-risk for familial Alzheimer's disease. , 2009, Current Alzheimer research.
[5] Philip Scheltens,et al. Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment , 2004, Neurology.
[6] J. Cummings,et al. The A431E mutation in PSEN1 causing Familial Alzheimer’s Disease originating in Jalisco State, Mexico: an additional fifteen families , 2006, Neurogenetics.
[7] Kiralee M. Hayashi,et al. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. , 2006, Archives of neurology.
[8] Toru Shimizu,et al. Clinical comparison of Alzheimer's disease in pedigrees with the codon 717 Val→Ile mutation in the amyloid precursor protein gene , 1993, Neurobiology of Aging.
[9] O Nalcioglu,et al. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease , 1991, Neurology.
[10] J. H. Lee,et al. A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families. , 2001, JAMA.
[11] P. Scheltens,et al. Visual assessment of medial temporal lobe atrophy on magnetic resonance imaging: Interobserver reliability , 1995, Journal of Neurology.
[12] W. M. van der Flier,et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. , 2009, JAMA.
[13] Nick C Fox,et al. Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study , 2006, The Lancet Neurology.
[14] R. Petersen. Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.
[15] Linda Teri,et al. Clinico‐Neuropathological Correlation of Alzheimer's Disease in a Community‐Based Case Series , 1999, Journal of the American Geriatrics Society.
[16] Nick C Fox,et al. Early onset familial Alzheimer’s disease , 2002, Neurology.
[17] J. Morris,et al. Clinical Dementia Rating: A Reliable and Valid Diagnostic and Staging Measure for Dementia of the Alzheimer Type , 1997, International Psychogeriatrics.